Skip to main content
Hematology and Oncology
FULL MENU
Close Menu
Hematology and Oncology
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Conference Coverage
Oral paclitaxel bests IV version for tumor response, neuropathy incidence in mBC
Publish date:
December 19, 2019
REPORTING FROM SABCS 2019
SOURCE:
Umanzor G et al. SABCS 2019, Abstract
GS6-01
.
Pages
« first
1
2
Next Article:
PEARL lacks luster in metastatic breast cancer progressing on AIs
Breast Cancer
Close
MDedge Home
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
COVID-19 Updates
Genitourinary Cancer
Renal Cell Carcinoma
Gastrointestinal Cancer
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
Transplantation
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Long COVID
Lung Cancer
Lymphoma and Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
Subspecialties
Immuno-oncology
Patient and Survivor Care
Pediatrics
Preventive Care
Transfusion Medicine
Translational Research
Business of Medicine
Diversity in Medicine
Explore
Business of Medicine
Explore
Law & Medicine
Medicolegal Issues
Movers in Medicine
Practice Management
Clinical Advances in Thrombocytopenia Series
CME
Career
Explore
For Residents
Lifestyle
Challenge Center
Explore
Lung Cancer Challenge Center
Prostate Cancer Challenge Center
Conference ReCAP
Expert Interview
Hem-Onc Board Review Archive
ICYMI: Breast Cancer
Latest News
Explore
Feature
From the Journals
Guidelines
Medicine’s Lighter Side
News by Conference
News from the FDA/CDC
Meeting Calendar
Multimedia
Explore
Audio
Explore
Blood & Cancer
MDedge Podcasts
Video
Original Reports
Explore
Case Reports
Patient Resources
Perspectives
Explore
Alan P. Lyss, MD: Clinical Insights
Bloodlines
Chronicles of Cancer
Commentary
Diminutio
Found In Translation
From the Editor of Hematology News
From the Editor of JCSO
Hard Questions
Lung Cancer Updates
The Practicing Oncologist
Physician Resources
Quizzes
Explore
Board Review Questions
MD-IQ
ReCAP
Research Summaries
Explore
Clinical Edge Journal Scan
Reviews
Explore
Board Review: Case-Based Reviews
Board Review: Clinical Review
Community Translations
How We Do It (How I Treat)
Roundtables
Sponsored Content
Explore
Adjuvant Therapy Advances and Optimization in Early Breast Cancer
First-line Treatment Considerations for Advanced/Metastatic Renal Cell Carcinoma
Newer Treatment Options Improve Outcomes in Unresectable Stage III NSCLC
Targeted Therapies as Initial Treatment of Advanced/Metastatic Non–Small Cell Lung Cancer
Treatment of Non-Small Cell Lung Cancer in the Older Population
Supplements
Explore
Rare Diseases: Cancer
Explore
2021 Rare Diseases: Cancer
2020 Rare Diseases: Cancer
2019 Rare Diseases: Cancer
The Sarcoma Journal
Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS
More
JCSO Issues
